In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

Scheduled for August 2025 completion, the initial $2-billion phase included construction of a 1-million-sq-ft complex with two drug substance manufacturing buildings, each containing four 20,000-liter ...

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

The "Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's offering. An active pharmaceutical ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump ...

VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...

Fujifilm Biotechnologies will open a new biologics manufacturing plant in the U.S. this fall, with Regeneron and Johnson & Johnson as the initial customers. The Holly Springs, North Carolina, site is ...